Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a new drug make gallbladder surgery recovery smoother?

NCT ID NCT07741188

Symptom relief Sponsor: Affiliated Hospital of Guangdong Medical University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This trial is testing whether an experimental drug called anrikefon can improve recovery and reduce pain after laparoscopic gallbladder removal, compared to a standard painkiller. Adults undergoing this surgery will receive either anrikefon or the standard drug, and their pain levels, sleep quality, and overall recovery will be tracked for 24 hours. The goal is to see if anrikefon offers better pain relief and a smoother recovery experience.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
anrikefon
What this could lead to
If it works, anrikefon could offer a new option for managing pain after gallbladder surgery, potentially improving recovery quality and reducing discomfort.
What could go wrong
This is an early-stage trial with a modest number of participants, so results may not be conclusive or apply to all patients. The drug may also have side effects, such as nausea or injection-site reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 144 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 1.18 ≤ Age ≤ 70 years, no gender restriction. * 2.American Society of Anesthesiologists (ASA) physical status classification I-II. * 3.18 kg/m² ≤ BMI ≤ 30 kg/m². * 4.Subjects undergoing elective LC under general anesthesia, with an estimated -surgical duration of ≤2 hours (including 1h). * 5.Voluntarily agree to participate in the study and sign the informed consent form (ICF). Exclusion Criteria: * 1.History of allergy to nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, or intraoperative anesthetics specified in the protocol. * 2.Severe systemic diseases that, in the investigator's judgment, may significantly increase surgical risk or interfere with pain assessment (e.g., uncontrolled hypertension \[SBP ≥170 mmHg and/or DBP ≥105 mmHg\], uncontrolled hyperglycemia \[fasting blood glucose ≥11.1 mmol/L\], recent severe respiratory tract infection, severe gastritis, gastric/duodenal ulcers, upper abdominal surgery within 3 months, severe hepatic impairment \[Child-Pugh score \>9\], chronic kidney disease \[eGFR \<60 mL/min/1.73m²\]). * 3.Substance abuse: Current drug or alcohol dependency. * 4.Special populations: Pregnant or lactating women; any other conditions deemed unsuitable by the investigator. * 5.Acute severe cholecystitis attack within the past 7 days, or subjects in whom malignant gallbladder lesions cannot be ruled out. * 6.Presence of sleep disorders requiring pharmacological intervention; concomitant psychiatric disorders.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gallbladder polyps are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cholecystolithiasis gallstones polyp of gallbladder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gallbladder polyps Gallbladder stones

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Affiliated Hospital of Guangdong Medical University

    Zhanjiang, Guangdong, 524001, China

  • The Second Affiliated Hospital of Guangdong Medical University

    Zhanjiang, Guangdong, 524001, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.